Literature DB >> 10963842

High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms.

T Yokose1, Y Ito, A Ochiai.   

Abstract

Atypical adenomatous hyperplasia (AAH) is a possible precursor lesion of adenocarcinoma of the lung, but there have been no reports of AAH focusing on autopsy studies of the lungs of elderly patients, who have higher lung cancer mortality rates. We intended to clarify the characteristics of AAH in the general elderly population on the basis of the findings in autopsy cases. A total of 19 AAH lesions were found microscopically in 16 out of 241 autopsy cases (6.6%). AAH was found in only two cases of adenocarcinoma among 28 lung cancer cases. p53 immunoreactivity was observed in one of 11 low-grade AAH lesions (9.1%), but in three of four high-grade AAH lesions (75%, P=0.03) and the cases of high-grade AAH were more frequently positive for Ki-67 and CEA than the low-grade cases and less positive for pro-surfactant apoprotein C. Four of 123 patients without malignant neoplasms (3.4%) and 12 of 118 patients with malignant neoplasms (11.1%) had AAH (P=0.03). The finding that AAH was more common in the cases with malignancy than in those without malignancy indicated that genesis of AAH may be closely associated with that of malignant neoplasms.

Entities:  

Mesh:

Year:  2000        PMID: 10963842     DOI: 10.1016/s0169-5002(00)00101-x

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  11 in total

1.  CT findings of atypical adenomatous hyperplasia in the lung.

Authors:  Chang Min Park; Jin Mo Goo; Hyun Ju Lee; Chang Hyun Lee; Hyo-Cheol Kim; Doo Hyun Chung; Jung-Gi Im
Journal:  Korean J Radiol       Date:  2006 Apr-Jun       Impact factor: 3.500

2.  Indeterminate pulmonary nodules: risk for having or for developing lung cancer?

Authors:  Pierre P Massion; Ronald C Walker
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-27

3.  Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.

Authors:  K Takamochi; T Ogura; K Suzuki; H Kawasaki; Y Kurashima; T Yokose; A Ochiai; K Nagai; Y Nishiwaki; H Esumi
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia.

Authors:  R Nakahara; T Yokose; K Nagai; Y Nishiwaki; A Ochiai
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

5.  Bronchioloalveolar neoplasia.

Authors:  Hitoshi Kitamura; Koji Okudela
Journal:  Int J Clin Exp Pathol       Date:  2010-11-12

6.  Synchronous pulmonary atypical adenomatous hyperplasia and metastatic osteosarcoma in a young female.

Authors:  Ken Kodama; Masahiko Higashiyama; Koji Takami; Naozumi Higaki; Kazuyuki Oda; Nobuhito Araki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-07

Review 7.  Lung cancer screening with CT.

Authors:  Denise R Aberle; Kathleen Brown
Journal:  Clin Chest Med       Date:  2008-03       Impact factor: 2.878

8.  Glucocorticoid Clearance and Metabolite Profiling in an In Vitro Human Airway Epithelium Lung Model.

Authors:  Dinelia Rivera-Burgos; Ujjal Sarkar; Amanda R Lever; Michael J Avram; Jonathan R Coppeta; John S Wishnok; Jeffrey T Borenstein; Steven R Tannenbaum
Journal:  Drug Metab Dispos       Date:  2015-11-19       Impact factor: 3.922

Review 9.  Preneoplastic lesions of the lung.

Authors:  Alissa K Greenberg; Herman Yee; William N Rom
Journal:  Respir Res       Date:  2002-04-04

10.  MCM2--a promising marker for premalignant lesions of the lung: a cohort study.

Authors:  D F Tan; J A Huberman; A Hyland; G M Loewen; J S Brooks; A F Beck; I T Todorov; G Bepler
Journal:  BMC Cancer       Date:  2001-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.